LEADER 03429nam  22006375  450 
001 9910254260603321
005 20200705004232.0
010   $a3-319-26728-0
024 7 $a10.1007/978-3-319-26728-9
035   $a(CKB)3150000000021329
035   $a(EBL)4411530
035   $a(SSID)ssj0001653307
035   $a(PQKBManifestationID)16433722
035   $a(PQKBTitleCode)TC0001653307
035   $a(PQKBWorkID)14982538
035   $a(PQKB)10336790
035   $a(DE-He213)978-3-319-26728-9
035   $a(MiAaPQ)EBC4411530
035   $a(PPN)192219227
035   $a(EXLCZ)993150000000021329
100   $a20160217d2016      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aAutoimmune Bullous Diseases $eApproach and Management /$fedited by Naveed Sami
205   $a1st ed. 2016.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2016.
215   $a1 online resource (273 p.)
300   $aIncludes index.
311   $a3-319-26726-4 
327   $aBullous pemphigoid -- Epidermolysis Bullosa Acquisita -- Linear IgA Bullous Disease -- Dermatitis Herpetiformis -- Bullous pemphigoid -- Epidermolysis Bullosa Acquisita -- Linear IgA Bullous Disease -- Dermatitis Herpetiformis -- Pemphigoid Gestationis -- Pediatric Bullous Diseases -- Pemphigus Vulgaris -- Pemphigus Foliaceus -- Ocular Cicatricial Pemphigoid -- Mucous Membrane Pemphigoid (extra ocular) -- Local therapy -- Systemic Steroids -- Pemphigoid Gestationis.
330   $aThis book provides a coherent synopsis on the treatment and management of autoimmune blistering diseases. Each chapter focuses on one condition, and summarizes the present-day literature on currently available therapies, and how they may fit into various feasible treatment algorithms. Many of these disorders can have irreversible consequences, and in some cases the potential to be fatal. The contributing authors are individuals who have devoted their careers to understanding these diseases, and have invested countless hours in their research laboratories and clinical settings. Autoimmune Bullous Diseases: Approach and Management serves as a guide in assisting clinicians to develop their approach to treatment based on the specific disease and its severity. The information and algorithms presented provide pragmatic direction and assistance in the management of patients with these diseases.
606   $aDermatology
606   $aImmunology
606   $aRheumatology
606   $aPediatrics
606   $aDermatology$3https://scigraph.springernature.com/ontologies/product-market-codes/H1900X
606   $aImmunology$3https://scigraph.springernature.com/ontologies/product-market-codes/B14000
606   $aRheumatology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33170
606   $aPediatrics$3https://scigraph.springernature.com/ontologies/product-market-codes/H49006
615  0$aDermatology.
615  0$aImmunology.
615  0$aRheumatology.
615  0$aPediatrics.
615 14$aDermatology.
615 24$aImmunology.
615 24$aRheumatology.
615 24$aPediatrics.
676   $a610
702   $aSami$b Naveed$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910254260603321
996   $aAutoimmune Bullous Diseases$92164499
997   $aUNINA